公司新闻
https://chimebiologics.com/wp-content/uploads/2026/08/banner-linkedin.png
649
1520
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-08-14 14:39:132026-08-14 14:39:13从生物工艺到数字时代：鼎康生物亮相 Bioprocessing Summit 2026
https://chimebiologics.com/wp-content/uploads/2026/08/banner-zhai-1.png
671
1317
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-08-07 10:47:482026-08-13 12:24:18百亿美元交易的背后：商业化生产权益正在成为中国生物药对外授权交易的新价值密码
https://chimebiologics.com/wp-content/uploads/2026/06/KV-2.png
669
1291
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-06-23 14:25:182026-06-30 14:03:25(English) Can New Entrants Win the Biosimilar Race? What Europe's Biosimilar Market Reveals About the Next Competitive Frontier
https://chimebiologics.com/wp-content/uploads/2026/06/Image4.jpg
846
1269
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-06-10 17:21:092026-06-12 15:02:27鼎康生物在全球生物药制造创新峰会上发布下一代全球生物药制造愿景
https://chimebiologics.com/wp-content/uploads/2026/06/1-scaled.jpg
1707
2560
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-06-01 14:55:042026-06-02 13:26:40鼎康生物与大熊制药达成战略合作，共同推进度普利尤单抗生物类似药全球开发与商业化
https://chimebiologics.com/wp-content/uploads/2026/05/KV-Website.png
673
1330
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-05-15 15:15:212026-05-15 17:08:00(English) From AI Vision to AI Execution
https://chimebiologics.com/wp-content/uploads/2026/05/2222.png
651
1134
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-05-14 14:55:272026-05-14 15:03:15鼎康生物亮相BIO Equity Europe 2026——推动AI生物制药从概念走向现实
https://chimebiologics.com/wp-content/uploads/2026/05/2222.png
651
1134
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-05-12 16:49:092026-06-10 16:22:10(English) Chime Biologics at BIO Equity Europe 2026 ---Turning AI into Biologics Reality Amid the New Global Biopharma Landscape